用户48783635432019-04-09 14:29
【汇众医疗】Navidea宣布重启NAV3-31的2b期临床试验,此后股价上升13%
$Navidea生物制药(NAVB)$ Navidea根据FDA的反馈,宣布重启对NAV3-31的2b期临床试验计划,评估成像剂Tc99m tilmanocept在类风湿性关节炎患者中的应用。此举促进该公司股价上升了13%。 查看全文网页链接查看全文
艾萨克的猫2018-10-23 23:00
$Navidea Biopharmaceuticals, Inc. (NAVB)$ Navidea Biopharmaceuticals, Inc. (NYSE American: NAVB) ("Navidea" or the "Company"), a company focused on the development of precision immunodiagnostic agents and immunotherapeutics, announced today the company will pr...查看全文
$Navidea Biopharmaceuticals, Inc.(NAVB)$ SC 13G - Statement of acquisition of beneficial ownership by individuals Filed: 2018-09-24 AccNo: 0001193125-18-281390 Size: 49 KB 网页链接
$Navidea Biopharmaceuticals, Inc.(NAVB)$ 8-K - Current report Filed: 2018-09-17 AccNo: 0001437749-18-017131 Size: 42 KBItem 1.01: Entry into a Material Definitive AgreementItem 9.01: Financial Statements and Exhibits 网页链接
$Navidea Biopharmaceuticals, Inc.(NAVB)$ 8-K - Current report Filed: 2018-08-21 AccNo: 0001437749-18-015945 Size: 243 KBItem 5.07: Submission of Matters to a Vote of Security HoldersItem 9.01: Financial Statements and Exhibits 网页链接
$Navidea Biopharmaceuticals, Inc.(NAVB)$ 8-K - Current report Filed: 2018-08-16 AccNo: 0001437749-18-015739 Size: 9 MBItem 8.01: Other EventsItem 9.01: Financial Statements and Exhibits 网页链接
$Navidea Biopharmaceuticals, Inc.(NAVB)$ DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material Filed: 2018-08-16 AccNo: 0001437749-18-015735 Size: 76 KB 网页链接
$Navidea Biopharmaceuticals, Inc.(NAVB)$ 8-K - Current report Filed: 2018-08-16 AccNo: 0001437749-18-015733 Size: 36 KBItem 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of ListingItem 9.01: Financial Statements and Exhibits ht...
$Navidea Biopharmaceuticals, Inc.(NAVB)$ 8-K - Current report Filed: 2018-08-15 AccNo: 0001437749-18-015682 Size: 25 KBItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers ...
$Navidea Biopharmaceuticals, Inc.(NAVB)$ 8-K - Current report Filed: 2018-08-09 AccNo: 0001437749-18-015009 Size: 188 KBItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits 网页链接
$Navidea Biopharmaceuticals, Inc.(NAVB)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2018-08-08 AccNo: 0001437749-18-014956 Size: 7 MB 网页链接
$Navidea Biopharmaceuticals, Inc.(NAVB)$ DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material Filed: 2018-07-20 AccNo: 0001437749-18-013527 Size: 67 KB 网页链接